SCIENCEDIRECT
1. Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19
Vaccine, 3 September 2021, Volume 39, Issue 41, Pages 6050-6056
Zehua Zhou, Xinyu Zhang, Weijin Huang
https://www.sciencedirect.com/science/article/pii/S0264410X21011658/pdfft?md5=5db7a91fe736398c5431c17309f4e91d&pid=1-s2.0-S0264410X21011658-main.pdf
2. Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques
Molecular Therapy - Methods & Clinical Development, 26 August 2021, Volume 23, Pages 108-118
Hongbo Chen, Zhongping Xie, Qihan Li
https://www.sciencedirect.com/science/article/pii/S2329050121001315/pdfft?md5=cb38ccef2823839c17fa2ac427563fc8&pid=1-s2.0-S2329050121001315-main.pdf
3. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients
Gene Reports, 27 November 2020, Volume 22 (Cover date: March 2021), Article 100980
Priyanka Ramesh, Shanthi Veerappapillai, Ramanathan Karuppasamy
https://www.sciencedirect.com/science/article/pii/S2452014420303940
4. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment
ESMO Open, 8 September 2021, Volume 6, Issue 5,Article 100274
M. Peeters, L. Verbruggen, P. van Dam
https://www.sciencedirect.com/science/article/pii/S2059702921002362/pdfft?md5=5fcafef5c34679a0ab2ba414d413a760&pid=1-s2.0-S2059702921002362-main.pdf
5. Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Volume 99, Issue 4 (Cover date: April 2021), Article 115294
Emelissa J. Valcourt, Kathy Manguiat, Heidi Wood
https://www.sciencedirect.com/science/article/pii/S0732889320306714/pdfft?md5=b521b4dbfda14f1862b7e0d07e7d3c0c&pid=1-s2.0-S0732889320306714-main.pdf
6. Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide
Virus Research, 30 July 2021, Volume 304, Article 198526
Filipa F. Vale, Jorge M. B. Vítor, Joao Goncalves
https://www.sciencedirect.com/science/article/pii/S0168170221002331/pdfft?md5=ce2869f091f3bc795ebbd6b6b923fddf&pid=1-s2.0-S0168170221002331-main.pdf
7. Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected
Journal of Infection, 25 July 2021, Volume 83, Issue 4, Pages 467-472
Anna Gidari, Samuele Sabbatini, Daniela Francisci
https://www.sciencedirect.com/science/article/pii/S0163445321003625/pdfft?md5=02f81b73c37052f3fb7934226511858a&pid=1-s2.0-S0163445321003625-main.pdf
8. Programmed −1 Ribosomal Frameshifting in coronaviruses: A therapeutic target
Virology, 25 December 2020, Volume 554 (Cover date: February 2021), Pages 75-82
Jamie A. Kelly, Michael T. Woodside, Jonathan D. Dinman
https://www.sciencedirect.com/science/article/pii/S0042682220302506/pdfft?md5=1d7c38458cbd28c5c5b17ab020622a27&pid=1-s2.0-S0042682220302506-main.pdf
9. A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19
Molecular Therapy, 14 May 2021, Volume 29, Issue 7, Pages 2219-2226
Adi Idris, Alicia Davis, Kevin V. Morris
https://www.sciencedirect.com/science/article/pii/S1525001621002562/pdfft?md5=5eccf8706ece4088476996b969eab98b&pid=1-s2.0-S1525001621002562-main.pdf
10. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
American Journal of Kidney Diseases, 24 June 2021, Volume 78, Issue 4, Pages 571-581
José Jesús Broseta, Diana Rodríguez-Espinosa, Francisco Maduell
https://www.sciencedirect.com/science/article/pii/S0272638621006892/pdfft?md5=9b67f3d27d76a88aa6792c386e020ee9&pid=1-s2.0-S0272638621006892-main.pdf
11. Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19
Journal of Molecular and Cellular Cardiology, 26 December 2020,
Volume 153 (Cover date: April 2021), Pages 72-85
https://www.sciencedirect.com/science/article/pii/S0022282820303497/pdfft?md5=f67edca1848b5b8b3341aa7d336e5ea2&pid=1-s2.0-S0022282820303497-main.pdf
12. Dual targeting of 3CLpro and PLpro of SARS-CoV-2: A novel structure-based design approach to treat COVID-19
Current Research in Structural Biology, 10 December 2020, Volume 3 (Cover date: 2021), Pages 9-18
Sajjan Rajpoot, Manikandan Alagumuthu, Mirza S. Baig
https://www.sciencedirect.com/science/article/pii/S2665928X20300258/pdfft?md5=940a18de0bfe3981630bf273b24651b8&pid=1-s2.0-S2665928X20300258-main.pdf
13. Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak
Computational Biology and Chemistry, 18 June 2021, Volume 93, Article 107533
Avizit Das, Sarah Khurshid, Fee Faysal Ahmed
https://www.sciencedirect.com/science/article/pii/S1476927121001006/pdfft?md5=e0437ba03b892004679083bbba5e6b8d&pid=1-s2.0-S1476927121001006-main.pdf
14. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
Journal of Virological Methods, 14 October 2020, Volume 287 (Cover date: January 2021), Article 113995
Jun-Gyu Park, Fatai S. Oladunni, Luis Martinez-Sobrido
https://www.sciencedirect.com/science/article/pii/S0166093420302470/pdfft?md5=de1ec0e64bd78d89f497dd92f613104e&pid=1-s2.0-S0166093420302470-main.pdf
15. Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry
Vaccine, 24 July 2021, Volume 39, Issue 36, Pages 5106-5115
Carrie Pierce-Ruiz, Wanda I. Santana, Tracie L. Williams
https://www.sciencedirect.com/science/article/pii/S0264410X21009592/pdfft?md5=88974987b57a132102a1978d6dbc935a&pid=1-s2.0-S0264410X21009592-main.pdf
16. Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
Journal of Traditional and Complementary Medicine, 4 January 2021, Volume 11, Issue 2, Pages 158-172
Panthakarn Rangsinth, Chanin Sillapachaiyaporn, Siriporn Chuchawankul
https://www.sciencedirect.com/science/article/pii/S2225411021000018/pdfft?md5=4542bc672e66bf34a592e5400becb332&pid=1-s2.0-S2225411021000018-main.pdf
17. Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
Cell Reports, 26 January 2021, Volume 34, Issue 7, Article 108737
Timothy A. Bates, Jules B. Weinstein, Fikadu G. Tafesse
https://www.sciencedirect.com/science/article/pii/S2211124721000504/pdfft?md5=bb275cb800a30dbb7250872ac6e7f0b0&pid=1-s2.0-S2211124721000504-main.pdf
18. Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies
Multiple Sclerosis and Related Disorders, 15 July 2021, Volume 54, Article 103150
Jelena Drulovic, Jovana Ivanovic, Tatjana Pekmezovic
https://www.sciencedirect.com/science/article/pii/S221103482100417X/pdfft?md5=70ea6339191e4fd87e316f83277ab633&pid=1-s2.0-S221103482100417X-main.pdf
19. Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2
Computational and Structural Biotechnology Journal, 28 December 2020, Volume 19 (Cover date: 2021), Pages 467-476
Haixia Zhu, Wenhao Du, Qiang Huang
https://www.sciencedirect.com/science/article/pii/S2001037020305602/pdfft?md5=b2887c9215f6fe9a985b375f6b0e4435&pid=1-s2.0-S2001037020305602-main.pdf
20. Therapeutic perceptions in antisense RNA-mediated gene regulation for COVID-19
Gene, 16 July 2021, Volume 800, Article 145839
Sabrina Ferreira de Jesu, sLaércio Ives Santos, André Luiz Sena Guimaraes
https://www.sciencedirect.com/science/article/pii/S0378111921004340/pdfft?md5=15b89e0843c28c24ce78c798a411c51b&pid=1-s2.0-S0378111921004340-main.pdf
21. Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients
iScience, 1 May 2021, Volume 24, Issue 6, Article 102489
Connor J. Dwyer, Colleen A. Cloud, Shikhar Mehrotra
https://www.sciencedirect.com/science/article/pii/S2589004221004570/pdfft?md5=4ccf3a878e8d62d8f9d1e61b43c99724&pid=1-s2.0-S2589004221004570-main.pdf
22. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction
Cell Reports, 26 December 2020, Volume 34, Issue 2 (Cover date: 12 January 2021), Article 108630
Sophie M. -C. Gobeil, Katarzyna Janowska, Priyamvada Acharya
https://www.sciencedirect.com/science/article/pii/S2211124720316193/pdfft?md5=2ab0498de58c3a8c45737114e3755618&pid=1-s2.0-S2211124720316193-main.pdf
23. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity
Cell Reports Medicine, 15 June 2021, Volume 2, Issue 7, Article 100329
Jennifer L. Yates, Dylan J. Ehrbar, William T. Lee
https://www.sciencedirect.com/science/article/pii/S2666379121001725/pdfft?md5=6a8dda4270d32ef7cc15cdf93aff9fa1&pid=1-s2.0-S2666379121001725-main.pdf
24. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
Immunity, 8 June 2021, Volume 54, Issue 7, Pages 1611-1621.e5
Ruoke Wang, Qi Zhang, Linqi Zhang
https://www.sciencedirect.com/science/article/pii/S1074761321002478/pdfft?md5=b54b25fb60378ed257dcdf1112249413&pid=1-s2.0-S1074761321002478-main.pdf
25. Pinpointing the potential hits for hindering interaction of SARS-CoV-2 S-protein with ACE2 from the pool of antiviral phytochemicals utilizing molecular docking and molecular dynamics (MD) simulations
Journal of Molecular Graphics and Modelling, 22 February 2021, Volume 105, Article 107874
Chirag N. Patel, Dweipayan Goswami, Himanshu A. Pandya
https://www.sciencedirect.com/science/article/pii/S1093326321000437/pdfft?md5=8a0e22ac074b245f55d151fc1843700e&pid=1-s2.0-S1093326321000437-main.pdf
26. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
Cell, 23 February 2021, Volume 184, Issue 8, Pages 2229-2238.e13
Xianwen Zhang, Yang Liu, Pei-Yong Shi
https://www.sciencedirect.com/science/article/abs/pii/S0092867421002336
27. Single-step, wash-free digital immunoassay for rapid quantitative analysis of serological antibody against SARS-CoV-2 by photonic resonator absorption microscopy
Talanta, 14 December 2020, Volume 225 (Cover date: 1 April 2021), Article 122004
Bin Zhao, Congnyu Che, Brian T. Cunningham
https://www.sciencedirect.com/science/article/pii/S0039914020312959/pdfft?md5=c1a3ee5795c32dc8e70c1d63d478d1f5&pid=1-s2.0-S0039914020312959-main.pdf
28. One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening
Cell Reports, 10 August 2021, Volume 36, Issue 9, Article 109627
Irene M. Francino-Urdaniz, Paul J. Steiner, Timothy A. Whitehead
https://www.sciencedirect.com/science/article/pii/S2211124721010652/pdfft?md5=d0985c65abc64a21723eb9cf45254332&pid=1-s2.0-S2211124721010652-main.pdf
29. Berries anthocyanins as potential SARS-CoV–2 inhibitors targeting the viral attachment and replication; molecular docking simulation
Egyptian Journal of Petroleum, 21 January 2021, Volume 30, Issue 1, Pages 33-43
Omar Messaoudi, Hicham Gouzi, Mourad Bendahou
https://www.sciencedirect.com/science/article/pii/S1110062121000015/pdfft?md5=137f275166bb4f54182c65c385e7f014&pid=1-s2.0-S1110062121000015-main.pdf
30. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples
Journal of Immunological Methods, 28 November 2020, Volume 489 (Cover date: February 2021), Article 112937
Livia Mazzini, Donata Martinuzzi, Emanuele Montomoli
https://www.sciencedirect.com/science/article/pii/S0022175920302313/pdfft?md5=d7ccc1c6479ff5c6056b8d41ef4d7250&pid=1-s2.0-S0022175920302313-main.pdf
31. Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19
Cell Reports, 9 May 2021, Volume 35, Issue 8, Article 109173
Zachary Montague, Huibin Lv, Chris Ka Pun Mok
https://www.sciencedirect.com/science/article/pii/S2211124721005180/pdfft?md5=670414faef1503a8578b5e2415146681&pid=1-s2.0-S2211124721005180-main.pdf
32. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals
EBioMedicine, 6 October 2021, Volume 72,Article 103610
Isaac Quiros-Fernandez, Mansour Poorebrahim, Angel Cid-Arregui
https://www.sciencedirect.com/science/article/pii/S2352396421004035/pdfft?md5=5a39f126e8ab7b0c8d151b0e20bb3675&pid=1-s2.0-S2352396421004035-main.pdf
33. In vitro cell culture model of human nasal-associated lymphoid tissue (NALT) to evaluate the humoral immune response to SARS-CoV-2 spike proteins
Saudi Journal of Biological Sciences, 24 April 2021, Volume 28, Issue 8, Pages 4516-4521
Waleed H. Mahallawi, Talal M. Aljeraisi
https://www.sciencedirect.com/science/article/pii/S1319562X21003144/pdfft?md5=7ec87930715eaf5ed25e4b59bbccfc6a&pid=1-s2.0-S1319562X21003144-main.pdf
34. Rapid and sensitive triple-mode detection of causative SARS-CoV-2 virus specific genes through interaction between genes and nanoparticles
Analytica Chimica Acta, 17 February 2021, Volume 1154, Article 338330
Yakun Gao, Yingkuan Han, Yu Zhang
https://www.sciencedirect.com/science/article/pii/S0003267021001562/pdfft?md5=6125bb3f0266f095c0bef9e239896e8b&pid=1-s2.0-S0003267021001562-main.pdf
35. In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding
Heliyon, 11 January 2021, Volume 7, Issue 1, Article e05923
Arijit Bhowmik, Souradeep Biswas, Prosenjit Saha
https://www.sciencedirect.com/science/article/pii/S2405844021000281/pdfft?md5=ecc1fa35849dd3fff93634c695525d0f&pid=1-s2.0-S2405844021000281-main.pdf
36. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
Cell Reports, 10 August 2021, Volume 36, Issue 8, Article 109604
Elaine C. Chen, Pavlo Gilchuk, James E. Crowe
https://www.sciencedirect.com/science/article/pii/S2211124721010421/pdfft?md5=a31e0f0e117b2916c7f75f0808dc0f6a&pid=1-s2.0-S2211124721010421-main.pdf
37. Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
Computational and Structural Biotechnology Journal, 31 December 2020, Volume 19 (Cover date: 2021), Pages 518-529
Edison Ong, Xiaoqiang Huang, Yongqun He
https://www.sciencedirect.com/science/article/pii/S200103702030564X/pdfft?md5=58bb83e20ddd47d6eaa97aba7774ebde&pid=1-s2.0-S200103702030564X-main.pdf
38. The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis
Kidney International, 18 July 2021, Volume 100, Issue 4, Pages 928-936
Maxime Espi, Xavier Charmetant, Olivier Thaunat
https://www.sciencedirect.com/science/article/pii/S0085253821006797/pdfft?md5=23e7967e0882b5126000e6071f180c6e&pid=1-s2.0-S0085253821006797-main.pdf
39. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Cell, 23 November 2020, Volume 184, Issue 1 (Cover date: 7 January 2021), Pages 169-183.e17
Lauren B. Rodda, Jason Netland, Marion Pepper
https://www.sciencedirect.com/science/article/abs/pii/S0092867420315658
40. Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein
Biophysical Journal, 21 January 2021, Volume 120, Issue 6, Pages 1060-1071
Takaharu Mori, Jaewoon Jung, Yuji Sugita
https://www.sciencedirect.com/science/article/pii/S0006349521000497/pdfft?md5=d92cb54d84991926d3fd7ff7ac04a9b9&pid=1-s2.0-S0006349521000497-main.pdf
41. Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting
Clinical Microbiology and Infection, 14 October 2020, Volume 27, Issue 3 (Cover date: March 2021), Pages 469.e9-469.e15
Jordan P. Skittrall, Michael Wilson, Hamid Jalal
https://www.sciencedirect.com/science/article/abs/pii/S1198743X20306145
42. In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools
Computers in Biology and Medicine, 28 August 2021, Volume 137, Article 104818
Anish Nag, Subhabrata Paul, Rita Kundu
https://www.sciencedirect.com/science/article/pii/S0010482521006120/pdfft?md5=d493bcac3e2cf6d8c40974c9dbc8c982&pid=1-s2.0-S0010482521006120-main.pdf
43. Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2
International Journal of Biological Macromolecules, 7 September 2021, Volume 190, Pages 409-416
Letian Li, Maopeng Wang, Chang Li
https://www.sciencedirect.com/science/article/pii/S0141813021019097/pdfft?md5=11e140883c1ade89442585042f07dc4f&pid=1-s2.0-S0141813021019097-main.pdf
44. Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
Virology, 11 September 2021, Volume 563, Pages 134-145
Shang Yu Gong, Debashree Chatterjee, Andrés Finzi
https://www.sciencedirect.com/science/article/pii/S0042682221001860/pdfft?md5=0f59b06e9d6e2601207fbd4604e0dece&pid=1-s2.0-S0042682221001860-main.pdf
45. Genomic evidence for reinfection with SARS-CoV-2: a case study
The Lancet Infectious Diseases, 12 October 2020, Volume 21, Issue 1 (Cover date: January 2021), Pages 52-58
Richard L Tillett, Joel R Sevinsky, Mark Pandori
https://www.sciencedirect.com/science/article/pii/S1473309920307647/pdfft?md5=eb76e7b56e0bf5162450238eb0ed93cf&pid=1-s2.0-S1473309920307647-main.pdf
46. Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19
Bioorganic Chemistry, 24 February 2021, Volume 110, Article 104772
Arif Ali, Nasim Sepay, Musheer Ahmad
https://www.sciencedirect.com/science/article/pii/S0045206821001498/pdfft?md5=2e5bebc97c83c1f240a807f883d09785&pid=1-s2.0-S0045206821001498-main.pdf
47. Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies
Journal of Molecular Biology, 14 July 2021, Volume 433, Issue 18, Article 167155
Jiahui Chen, Kaifu Gao, Guo-Wei Wei
https://www.sciencedirect.com/science/article/pii/S0022283621003843/pdfft?md5=afbd0e887b4ceb8194c619e1a3006737&pid=1-s2.0-S0022283621003843-main.pdf
48. Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
iScience, 2 September 2021, Volume 24, Issue 9, Article 103078
Klara Asplund Högelin, Nicolas Ruffin, Faiez Al Nimer
https://www.sciencedirect.com/science/article/pii/S2589004221010464/pdfft?md5=51dc7a36d39c6201091f698f992e1989&pid=1-s2.0-S2589004221010464-main.pdf
49. Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2
Journal of Infection and Public Health, 15 December 2020, Volume 14, Issue 2 (Cover date: February 2021), Pages 169-178
Reham M. Dawood, Mai A. El-Meguid, Mostafa K. El Awady
https://www.sciencedirect.com/science/article/pii/S1876034120307620/pdfft?md5=42a23666c64f0a09d38cd64858ee6c52&pid=1-s2.0-S1876034120307620-main.pdf
50. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
The Lancet Infectious Diseases, 17 November 2020, Volume 21, Issue 2 (Cover date: February 2021), Pages 181-192
Yanjun Zhang, Gang Zeng, Fengcai Zhu
https://www.sciencedirect.com/science/article/pii/S1473309920308434/pdfft?md5=72aee1b11caaa620b930d87157b9a2ba&pid=1-s2.0-S1473309920308434-main.pdf
WILEY:
1. Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19
Anna Lee, Chung Hyun Nahm, Jin-Soo Lee, Mi-Kyeong Lee, Kyoung-Ryul Lee
Journal of Clinical Laboratory Analysis
First published: 05 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.24004
2. A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens
Fernanda Langellotto, Maxence O. Dellacherie, Chyenne Yeager, Hamza Ijaz, Jingyou Yu, Chi-An Cheng, Nikolaos Dimitrakakis, Benjamin T. Seiler, Makda S. Gebre, Tal Gilboa, Rebecca Johnson, Nadia Storm, Sarai Bardales, Amanda Graveline, Des White, Christina M. Tringides, Mark J. Cartwright, Edward J. Doherty, Anna Honko, Anthony Griffiths, Dan H. Barouch, David R. Walt, David J. Mooney
Advanced Healthcare Materials
First published: 04 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/adhm.202101370
3. Histological findings of tracheal samples from COVID-19 positive critically ill mechanically ventilated patients
P.A. Ward, J. Collier, J. Weir, M. Osborn, B. Hanley, W.J.B. Smellie, Chelwest COVID-19 Tracheostomy Group
Clinical Otolaryngology
First published: 04 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/coa.13872
4. Predictive role of FAR ratio in Covid-19 patients
Deniz Çekiç, Mehmet Emir Arman, Ahmed Cihad Genç, Kubilay İşsever, İlhan Yıldırım, Ahmed Bilal Genç, Hamad Dheir, Selçuk Yaylacı
International Journal of Clinical Practice
First published: 04 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijcp.14931
5. Gamma-glutamyl-transferase may predict COVID-19 outcomes in hospitalized patients
Benan Kasapoglu, Ahmet Yozgat, Alpaslan Tanoglu, Guray Can, Yusuf Serdar Sakin, Murat Kekilli
International Journal of Clinical Practice
First published: 04 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijcp.14933
6. Post-infection pulmonary sequelae after COVID-19 among patients with lung transplantation
Luke D. Mahan, Isaac Lill, Quinn Halverson, Manish R. Mohanka, Adrian Lawrence, John Joerns, Srinivas Bollineni, Vaidehi Kaza, Ricardo M. La Hoz, Song Zhang, Corey D. Kershaw, Lance S. Terada, Fernando Torres, Amit Banga
Transplant Infectious Disease
First published: 04 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tid.13739
7. Antibody response to two doses of inactivated SARS-CoV-2 vaccine (CoronaVac) in Kidney Transplant Recipients
Rezzan Eren Sadioğlu, Erol Demir, Ebru Evren, Merve Aktar, Seda Şafak, Ayşe Serra Artan, Sevim Meşe, Ali Ağaçfidan, Güle Çınar, Mustafa Önel, Zeynep Ceren Karahan, Şule Şengül, Kenan Keven, Aydın Türkmen
Transplant Infectious Disease
First published: 04 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tid.13740
8. The safety profile of favipiravir in COVID-19 patients with severe renal impairment
Selim Gök, Ömer Faruk Bahçecioğlu, Mefküre Durmuş, Zeynep Ülkü Gün, Yasemin Ersoy, Zeynep Ayfer Aytemur, Özkan Ulutaş
International Journal of Clinical Practice
First published: 03 October 2021.
https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijcp.14938
9. Outcomes of Tocilizumab Therapy in Severe or Critical COVID-19 Patients: A Retrospective Cohort, Single-Center Study
Hassan Abdelnaby, Wael Aboelhassan, Mohammed Al-Jarallah, Rajesh Rajan, Raja Dashti, Ahmad R. Al Saber, Ahmed Abd el-Saleem, Islam Ashri, Mohammed Abdullah, Ahmed Mahmud Fouad
Tropical Medicine & International Health
First published: 03 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tmi.13685
10. Characterization of SARS-CoV-2 and common cold coronavirus-specific T cell responses in MIS-C and Kawasaki disease children
Li-En Hsieh, Alba Grifoni, John Sidney, Chisato Shimizu, Hiroko Shike, Nanda Ramchandar, Elizabeth Moreno, Adriana H. Tremoulet, Jane C. Burns, Alessandra Franco
European Journal of Immunology
First published: 02 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202149556
11. Establishing an internal quality control method for the stable extraction of nucleic acids of severe acute respiratory syndrome coronavirus 2 and RT-PCR-based detection
Takahiro Okuyama, Kouki Ohtsuka, Wataru Ogura, Shota Yonetani, Satoko Yamasaki, Hiroyuki Miyagi, Kumiko Sekiguchi, Hiroaki Ohnishi, Takashi Watanabe
Journal of Clinical Laboratory Analysis
First published: 02 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.23998
12. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections
Rita Gaspari, Giorgia Spinazzola, Luciana Teofili, Alfonso W. Avolio, Barbara Fiori, Gianmarco Maresca, Teresa Spanu, Nicola Nicolotti, Gennaro De Pascale, Massimo Antonelli
European Journal of Clinical Investigation
First published: 02 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/eci.13687
13. SARS-CoV-2 Alpha, Beta and Delta variants display enhanced Spike-mediated Syncytia Formation
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, Nell Saunders, Remy Robinot, Ludivine Grzelak, Delphine Planas, Jérémy Dufloo, Stacy Gellenoncourt, Alice Bongers, Marija Zivaljic, Cyril Planchais, Florence Guivel-Benhassine, Françoise Porrot, Hugo Mouquet, Lisa A Chakrabarti, Julian Buchrieser, Olivier Schwartz
The EMBO Journal
https://www.embopress.org/doi/epdf/10.15252/embj.2021108944
14. Turn up the lights, leave them on, and shine them all around ‐ numerical simulations point the way to more efficient use of Far‐UVC lights for the inactivation of airborne coronavirus
Kenneth Wood, Andrew Wood, Camilo Peñaloza, Ewan Eadie
Photochemistry and Photobiology
First published: 02 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/php.13523
15. The effect of COVID‐19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross‐sectional, comparative study
Ecem Bostan MD, Fethi Zaid MD, Aysen Karaduman MD, Sibel Dogan MD, Duygu Gulseren MD, Basak Yalici-Armagan MD, Neslihan Akdogan MD, Sibel Ersoy-Evans MD, Gonca Elcin MD
Journal of Cosmetic Dermatology
First published: 02 October 2021
https://onlinelibrary.wiley.com/doi/epdf/10.1111/jocd.14484
Các công bố về COVID-19 trước thời gian trên:
Cập nhật các công bố về COVID-19 từ ngày 24/09 đến ngày 01/10/2021
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-24-9-den-ngay-01-10-2021-4058.html
Cập nhật các công bố về COVID-19 từ ngày 17/09 đến ngày 24/09/2021
https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-17-9-den-24-9-2021-4028.html
Cập nhật các công bố về COVID-19 từ ngày 10/09 đến ngày 17/09/2021
https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-9-den-ngay-17-9-2021-4002.html
Cập nhật các công bố về COVID-19 từ ngày 27/08 đến ngày 03/09/2021
https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-8-den-ngay-3-9-2021-3953.html
Cập nhật các công bố về COVID-19 từ ngày 20/08 đến ngày 27/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-8-den-ngay-27-8-2021-3932.html
Cập nhật các công bố về COVID-19 từ ngày 13/08 đến ngày 20/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-8-den-ngay-20-8-2021-3904.html
Cập nhật các công bố về COVID-19 từ ngày 06/08 đến ngày 13/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-6-8-den-ngay-13-8-2021-3878.html
Cập nhật các công bố về COVID-19 từ ngày 30/07 đến ngày 06/08/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-7-den-ngay-6-8-2021-3849.html
Cập nhật các công bố về COVID-19 từ ngày 23/07 đến ngày 30/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-7-den-ngay-30-7-2021-3823.html
Cập nhật các công bố về COVID-19 từ ngày 16/07 đến ngày 23/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-07-den-ngay-23-07-2021-3797.html
Cập nhật các công bố về COVID-19 từ ngày 09/07 đến ngày 16/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-07-den-ngay-16-07-2021-3769.html
Cập nhật các công bố về COVID-19 từ ngày 02/07 đến ngày 09/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-7-2021-den-ngay-9-7-2021-3744.html
Cập nhật các công bố về COVID-19 từ ngày 25/06 đến ngày 02/07/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-25-6-den-ngay-02-7-2021-3716.html
Cập nhật các công bố về COVID-19 từ ngày 18/06 đến ngày 25/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-6-den-ngay-25-6-2021-3692.html
Cập nhật các công bố về COVID-19 từ ngày 11/06 đến ngày 18/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-11-06-den-ngay-18-06-2021-3663.html
Cập nhật các công bố về COVID-19 từ ngày 04/06 đến ngày 11/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-04-06-den-ngay-11-6-2021-3642.html
Cập nhật các công bố về COVID-19 từ ngày 28/05 đến ngày 04/06/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-28-05-den-ngay-04-06-2021-3624.html
Cập nhật các công bố về COVID-19 từ ngày 21/05 đến ngày 28/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-05-den-ngay-28-05-2021-3598.html
Cập nhật các công bố về COVID-19 từ ngày 14/05 đến ngày 21/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-14-05-den-ngay-21-05-2021-3582.html
Cập nhật các công bố về COVID-19 từ ngày 07/05 đến ngày 14/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-05-den-ngay-14-05-2021-3557.html
Cập nhật các công bố về COVID-19 từ ngày 30/04 đến ngày 07/05/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-04-den-ngay-07-05-2021-3530.html
Cập nhật các công bố về COVID-19 từ ngày 23/04 đến ngày 30/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-04-den-ngay-30-04-2021-3509.html
Cập nhật các công bố về COVID-19 từ ngày 16/04 đến ngày 23/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-04-den-ngay-23-04-2021-3484.html
Cập nhật các công bố về COVID-19 từ ngày 09/04 đến ngày 16/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-04-den-ngay-19-04-2021-3474.html
Cập nhật các công bố về COVID-19 từ ngày 02/04 đến ngày 09/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-04-den-ngay-09-04-2021-3432.html
Cập nhật các công bố về COVID-19 từ ngày 26/03 đến ngày 02/04/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-03-den-ngay-02-04-2021-3408.html
Cập nhật các công bố về COVID-19 từ ngày 19/03 đến ngày 26/03/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-03-den-ngay-26-03-2021-3386.html
Cập nhật các công bố về COVID-19 từ ngày 12/03 đến ngày 19/03/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-12-3-den-ngay-19-3-2021-3376.html
Cập nhật các công bố về COVID-19 từ ngày 26/02 đến ngày 04/03/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-02-den-ngay-4-3-2021-3336.html
Cập nhật các công bố về COVID-19 từ ngày 09/02 đến ngày 25/02/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-02-den-ngay-25-02-2021-3319.html
Cập nhật các công bố về COVID-19 từ ngày 23/01 đến ngày 29/01/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-01-den-ngay-29-01-2021-3250.html
Cập nhật các công bố về COVID-19 từ ngày 09/01 đến ngày 15/01/2021
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-01-den-ngay-15-01-2021-3211.html
Cập nhật các công bố về COVID-19 từ ngày 18/12 đến ngày 24/12/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-12-den-ngay-24-12-2020-3174.html
Cập nhật các công bố về COVID-19 từ ngày 05/12 đến ngày 17/12/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-12-den-ngay-17-12-2020-3160.html
Cập nhật các công bố về COVID-19 từ ngày 15/11 đến ngày 22/11/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-11-den-ngay-22-11-2020-3123.html
Cập nhật các công bố về COVID-19 từ ngày 02/10 đến ngày 09/11/2020
https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-10-den-ngay-09-11-2020-3107.html
Cập nhật các công bố về COVID-19 từ ngày 26/9 đến ngày 02/10/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-9-den-ngay-02-10-2020-3027.html
Cập nhật các công bố về COVID-19 từ ngày 19/9 đến ngày 25/9/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-9-den-ngay-25-9-2020-3010.html
Cập nhật các công bố về COVID-19 từ ngày 05/9 đến ngày 11/9/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-9-den-ngay-11-9-2020-2969.html
Cập nhật các công bố về COVID-19 từ ngày 29/8 đến ngày 04/9/2020
http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-29-8-den-ngay-04-9-2020-2944.html
Cập nhật các công bố về COVID-19 từ ngày 21/8 đến ngày 28/8/2020
http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-8-den-ngay-28-8-2020-2929.html
Cập nhật các công bố về VACCINE COVID-19 tháng 8 năm 2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-vaccine-covid-19-2900.html
Cập nhật các công bố về COVID-19 từ ngày 08/8 đến ngày 14/8/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-8-den-ngay-14-8-2020-2866.html
Cập nhật các công bố về COVID-19 từ ngày 27/7 đến ngày 07/8/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-7-den-ngay-07-8-2020-2826.html
Cập nhật các công bố về COVID-19 từ ngày 15/7 đến ngày 26/7/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-7-den-ngay-26-7-2020-2779.html
Cập nhật các công bố về COVID-19 từ ngày 05/7 đến ngày 13/7/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-7-den-ngay-13-7-2020-2723.html
Cập nhật các công bố về COVID-19 từ ngày 22/6 đến ngày 30/6/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-22-6-den-ngay-30-6-2020-2681.html
Cập nhật các công bố về COVID-19 từ ngày 15/6 đến ngày 21/6/2020
https://www.most.gov.vn/vn/tin-tuc/17959/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-6-den-ngay-21-6-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 07/6 đến ngày 14/6/2020
http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-6-den-ngay-14-6-2020-2580.html
Cập nhật các công bố về COVID-19 đến ngày 07/6/2020
http://www.vista.gov.vn/news/khoa-hoc-ky-thuat-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-01-6-den-ngay-07-6-2020-2553.html
Cập nhật các công bố về COVID-19 đến ngày 01/6/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-den-ngay-01-6-2020-2524.html
Cập nhật các công bố về COVID-19 từ ngày 15/5 tới ngày 21/5/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-5-den-ngay-24-5-2020-2478.html
Cập nhật các công bố về COVID-19 từ ngày 08/5 tới ngày 14/5/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-5-den-ngay-14-5-2020-2436.html
Cập nhật các công bố về COVID-19 từ ngày 30/4 tới ngày 07/5/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-4-den-ngay-07-5-2020-2406.html
Cập nhật các công bố về COVID-19 từ ngày 24/4 tới ngày 30/4/2020
http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-24-4-den-ngay-30-4-2020-2375.html
Cập nhật các công bố về COVID-19 từ ngày 17/4 tới ngày 23/4/2020
https://www.most.gov.vn/vn/tin-tuc/17695/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-17-4-den-ngay-23-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 10/4 tới ngày 16/4/2020
https://www.most.gov.vn/vn/tin-tuc/17655/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-4--den-ngay-16-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 03/4 tới ngày 09/4/2020
https://www.most.gov.vn/vn/tin-tuc/17630/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-3-4--den-ngay-9-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 27/3 tới ngày 02/4/2020
https://www.most.gov.vn/vn/tin-tuc/17609/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-3-den-ngay-02-4-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 20/3 tới ngày 26/3/2020
https://www.most.gov.vn/vn/tin-tuc/17597/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-3-den-ngay-26-3-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 13/3 tới ngày 19/3/2020
https://www.most.gov.vn/vn/tin-tuc/17575/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-3-den-ngay-19-3-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 06/3 tới ngày 12/3/2020
https://www.most.gov.vn/vn/tin-tuc/17547/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-06-3-den-ngay-12-3-2020.aspx
Cập nhật các công bố về COVID-19 từ ngày 28/02 tới ngày 05/3/2020
http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20781/language/vi-VN/Default.aspx?seo=Cap-nhat-cac-cong-bo-moi-ve-COVID-19-den-ngay-05/3/2020&language=vi-VN
Cập nhật các công bố về COVID-19 từ ngày 11/02 tới ngày 27/02/2020
http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20740/seo/20740/language/vi-VN/language/vi-VN/Default.aspx
Cập nhật các công bố về virus corona từ tháng 11/2019 tới ngày 10/02/2020
http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20678/seo/20678/language/vi-VN/Default.aspx